MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 10, 2007; DOI: 10.1124/mol.107.038307


0026-895X/07/7204-921-933$20.00
Mol Pharmacol 72:921-933, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.038307v1
72/4/921    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pal, A.
Right arrow Articles by Ruoho, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pal, A.
Right arrow Articles by Ruoho, A. E.

Identification of Regions of the {sigma}-1 Receptor Ligand Binding Site Using a Novel Photoprobe

Arindam Pal, Abdol R. Hajipour, Dominique Fontanilla, Subramaniam Ramachandran, Uyen B. Chu, Timur Mavlyutov, and Arnold E. Ruoho

Department of Pharmacology, University of Wisconsin Medical School, Madison, Wisconsin (A.P., D.F., S.R., U.B.C., T.M., A.E.R.); and Pharmaceutical Research Laboratory, College of Chemistry, Isfahan University of Technology, Isfahan, Iran (A.R.H.)

{sigma} Receptors, once considered a class of opioid receptors, are now regarded as a unique class of receptors that contain binding sites for a wide range of ligands, including the drug 1-N(2',6'-dimethylmorpholino)3-(4-t-butylpropylamine) (fenpropimorph), a yeast sterol isomerase inhibitor. Because fenpropimorph has high-binding affinity to the {sigma}-1 receptor, we have synthesized a series of fenpropimorph-like derivatives with varying phenyl ring substituents and have characterized their binding affinities to the {sigma}-1 receptor. In addition, we have synthesized a carrier-free, radioiodinated fenpropimorph-like photoaffinity label, 1-N-(2',6'-dimethyl-morpholino)-3-(4-azido-3-[125I]iodo-phenyl)propane ([125I]IAF), which covalently derivatized the {sigma}-1 receptor (25.3 kDa) in both the rat liver and guinea pig liver membranes and the {sigma}-2 receptor (18 kDa) in rat liver membranes with high specificity. Furthermore, after cleaving the specific [125I]IAF-photolabeled {sigma}-1 receptor in guinea pig and rat liver membranes and the pure guinea pig {sigma}-1 receptor with EndoLys-C and cyanogen bromide, the [125I]IAF label was identified both in a peptide containing steroid binding domain-like I (SBDLI) (amino acids 91–109) and in a peptide containing steroid binding domain-like II (SBDLII) (amino acids 176–194). Because a single population of binding sites (R2 = 0.992) for [125I]IAF interaction with the {sigma}-1 receptor was identified by (+)-[3H]pentazocine competitive binding with nonradioactive [127I]IAF, it was concluded that SBDLI (amino acids 91–109) and SBDLII (amino acids 176–194) comprises, at least in part, regions of the {sigma}-1 receptor ligand binding site(s).


Received for publication May 18, 2007.

Accepted for publication July 10, 2007.

Address correspondence to: Dr. Arnold E. Ruoho, Department of Pharmacology, University of Wisconsin Medical School, 1300 University Avenue, Madison, WI 53706. E-mail: aeruoho{at}wisc.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Johannessen, S. Ramachandran, L. Riemer, A. Ramos-Serrano, A. E. Ruoho, and M. B. Jackson
Voltage-gated sodium channel modulation by {sigma}-receptors in cardiac myocytes and heterologous systems
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1049 - C1057.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. Fontanilla, M. Johannessen, A. R. Hajipour, N. V. Cozzi, M. B. Jackson, and A. E. Ruoho
The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Science, February 13, 2009; 323(5916): 934 - 937.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Wu and W. D. Bowen
Role of Sigma-1 Receptor C-terminal Segment in Inositol 1,4,5-Trisphosphate Receptor Activation: CONSTITUTIVE ENHANCEMENT OF CALCIUM SIGNALING IN MCF-7 TUMOR CELLS
J. Biol. Chem., October 17, 2008; 283(42): 28198 - 28215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pal, U. B. Chu, S. Ramachandran, D. Grawoig, L.-W. Guo, A. R. Hajipour, and A. E. Ruoho
Juxtaposition of the Steroid Binding Domain-like I and II Regions Constitutes a Ligand Binding Site in the {sigma}-1 Receptor
J. Biol. Chem., July 11, 2008; 283(28): 19646 - 19656.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics